Signal Advisors Wealth LLC Has $1.26 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Signal Advisors Wealth LLC reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 39.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,112 shares of the biotechnology company's stock after selling 1,354 shares during the period. Signal Advisors Wealth LLC's holdings in Axon Enterprise were worth $1,255,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Quent Capital LLC lifted its position in shares of Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company's stock worth $32,000 after acquiring an additional 75 shares during the period. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after buying an additional 44 shares during the period. Brooklyn Investment Group acquired a new position in Axon Enterprise during the third quarter worth $41,000. Planning Capital Management Corp lifted its holdings in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company's stock valued at $48,000 after acquiring an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at $51,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the firm's stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now owns 2,392 shares of the company's stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock valued at $30,721,337 in the last three months. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded up $6.67 during mid-day trading on Wednesday, reaching $586.47. 151,185 shares of the company were exchanged, compared to its average volume of 627,421. The stock has a market capitalization of $44.72 billion, a P/E ratio of 151.54, a P/E/G ratio of 14.19 and a beta of 1.04. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company's 50-day simple moving average is $612.80 and its 200-day simple moving average is $454.94. Axon Enterprise, Inc. has a twelve month low of $246.99 and a twelve month high of $698.67.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on AXON shares. Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a report on Friday, November 8th. TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a research report on Monday, November 11th. Robert W. Baird lifted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and an average price target of $504.92.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.